Evolution of Health-related Quality of Life Two to Seven Years After Retropubic Radical Prostatectomy: Evaluation by UCLA Prostate Cancer Index

Overview

Journal World J Urol

Specialty Urology

Date 2005 Sep 2

PMID 16136358

Citations 1

Authors

Aurelien Descazeaud

Marc Zerbib

Matthias D Hofer

Joel Chaskalovic

Bernard Debre

Michael Peyromaure

Affiliations

Soon will be listed here.

Abstract

To determine changes in health-related quality of life (HRQOL) in patients treated with retropubic radical prostatectomy (RP) between two and seven years after surgery. A questionnaire from the University of California Los Angeles Prostate Index was sent to 142 patients previously treated with retropubic RP as mono-therapy for clinically localized prostate cancer. Patients were divided into five groups according to time from surgery. Demographics, clinical and pathological characteristics of patients were compared between these groups. Correlation coefficients controlled for age at the time of questionnaire between HRQOL scores and time from RP were assessed. A total of 105 patients (74%) returned the questionnaire. The mean time from surgery was 48 months (range 25-84). Demographics, clinical and pathological characteristics of patients were not statistically different between time groups. Several recoding items were found to decrease significantly with the time from RP including physical functioning, role limitations due to physical health problem, vitality, and general health. In contrary, urinary, bowel and sexual scores were not significantly correlated to time from RP. Although sexual, urinary and bowel scores seem to remain stable from 2 to 7 years following RP, general health appears to significantly deteriorate with time after RP, independent of the patient's age at the time of the questionnaire.

Citing Articles

Development and Initial Validation of the Novel Scale for Assessing Quality of Life of Prostate Cancer Patients Receiving Androgen Deprivation Therapy.

Dun Y, Liu H, Yu L, Li Q, Zhang X, Tang X Chin Med J (Engl). 2017; 130(17):2082-2087.

PMID: 28836552 PMC: 5586177. DOI: 10.4103/0366-6999.213416.

References

. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology. J Clin Oncol. 1996; 14(2):671-9. DOI: 10.1200/JCO.1996.14.2.671. View

Salomon L, Levrel O, De La Taille A, Anastasiadis A, Saint F, Zaki S . Radical prostatectomy by the retropubic, perineal and laparoscopic approach: 12 years of experience in one center. Eur Urol. 2002; 42(2):104-10; discussion 110-1. DOI: 10.1016/s0302-2838(02)00263-4. View

Hara I, Kawabata G, Miyake H, Hara S, Fujisawa M, Okada H . Feasibility and usefulness of laparoscopic radical prostatectomy: Kobe University experience. Int J Urol. 2003; 9(11):635-40. DOI: 10.1046/j.1442-2042.2002.00530.x. View

Almeras C, Zerbib M, Eschwege F, Debre B . [UCLA/RAND Cancer Prostate Index quality of life questionnaire after external beam radiotherapy for localized prostate cancer: repercussions of complications and quality of life in general]. Prog Urol. 2003; 13(2):256-65. View

Hu J, Elkin E, Pasta D, Lubeck D, Kattan M, Carroll P . Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol. 2004; 171(2 Pt 1):703-7. DOI: 10.1097/01.ju.0000107964.61300.f6. View

Karakiewicz P, Kattan M, Tanguay S, Elhilali M, Bazinet M, Scardino P . Cross-cultural validation of the UCLA prostate cancer index. Urology. 2003; 61(2):302-7. DOI: 10.1016/s0090-4295(02)02245-8. View

Artibani W, Grosso G, Novara G, Pecoraro G, Sidoti O, Sarti A . Is laparoscopic radical prostatectomy better than traditional retropubic radical prostatectomy? An analysis of peri-operative morbidity in two contemporary series in Italy. Eur Urol. 2003; 44(4):401-6. DOI: 10.1016/s0302-2838(03)00315-4. View

Litwin M, Pasta D, Yu J, Stoddard M, Flanders S . Urinary function and bother after radical prostatectomy or radiation for prostate cancer: a longitudinal, multivariate quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol. 2000; 164(6):1973-7. DOI: 10.1016/s0022-5347(05)66931-5. View

Downs T, Sadetsky N, Pasta D, Grossfeld G, Kane C, Mehta S . Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE. J Urol. 2003; 170(5):1822-7. DOI: 10.1097/01.ju.0000091426.55735.f0. View

10.

van Andel G, Visser A, Hulshof M, Horenblas S, Kurth K . Health-related quality of life and psychosocial factors in patients with prostate cancer scheduled for radical prostatectomy or external radiation therapy. BJU Int. 2003; 92(3):217-22. DOI: 10.1046/j.1464-410x.2003.04321.x. View

11.

Cooperberg M, Koppie T, Lubeck D, Ye J, Grossfeld G, Mehta S . How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE. Urology. 2003; 61(1):190-6. DOI: 10.1016/s0090-4295(02)02118-0. View

12.

. Guidelines on the management of prostate cancer. A document for local expert groups in the United Kingdom preparing prostate management policy documents. BJU Int. 1999; 84(9):987-1014. View

13.

Litwin M, Hays R, Fink A, Ganz P, Leake B, Brook R . The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care. 1998; 36(7):1002-12. DOI: 10.1097/00005650-199807000-00007. View

14.

. A preliminary report on a patient-preference study to compare treatment options in early prostate cancer. BJU Int. 2002; 90(3):253-6. DOI: 10.1046/j.1464-410x.2002.02842.x. View

15.

Braslis K, Brickman A, Soloway M . Quality of life 12 months after radical prostatectomy. Br J Urol. 1995; 75(1):48-53. DOI: 10.1111/j.1464-410x.1995.tb07231.x. View

16.

Hays R, Sherbourne C, Mazel R . The RAND 36-Item Health Survey 1.0. Health Econ. 1993; 2(3):217-27. DOI: 10.1002/hec.4730020305. View

17.

Guillonneau B, Rozet F, Barret E, Cathelineau X, Vallancien G . Laparoscopic radical prostatectomy: assessment after 240 procedures. Urol Clin North Am. 2001; 28(1):189-202. DOI: 10.1016/s0094-0143(01)80021-5. View

18.

Litwin M, Hays R, Fink A, Ganz P, Leake B, Leach G . Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995; 273(2):129-35. DOI: 10.1001/jama.273.2.129. View

19.

Salomon L, Saint F, Anastasiadis A, Sebe P, Chopin D, Abbou C . Combined reporting of cancer control and functional results of radical prostatectomy. Eur Urol. 2003; 44(6):656-60. DOI: 10.1016/j.eururo.2003.09.009. View

20.

Norderhaug I, Dahl O, Hoisaeter P, Heikkila R, Klepp O, Olsen D . Brachytherapy for prostate cancer: a systematic review of clinical and cost effectiveness. Eur Urol. 2003; 44(1):40-6. DOI: 10.1016/s0302-2838(03)00187-8. View